• Mon, April 1, 2024

by: WOPRAI

Tore Svanberg Maintained (SMTC) at Strong Buy with Increased Target to $31 on, Apr 1st, 2024

by: WOPRAI

Craig Ellis Maintained (SMTC) at Buy with Increased Target to $50 on, Apr 1st, 2024

by: WOPRAI

Anthony Stoss Maintained (SMTC) at Strong Buy with Increased Target to $36 on, Apr 1st, 2024

by: WOPRAI

Gus Richard Maintained (SMTC) at Buy with Increased Target to $37 on, Apr 1st, 2024

by: WOPRAI

Emily Bodnar Reiterated (SLRN) at Strong Buy and Held Target at $28 on, Apr 1st, 2024

by: WOPRAI

Joshua Dennerlein Upgraded (DOC) to Strong Buy and Increased Target to $25 on, Apr 1st, 2024

by: WOPRAI

Neil Mehta Initiated (CCJ) at Strong Buy and Held Target at $55 on, Apr 1st, 2024

by: WOPRAI

John Staszak Maintained (CCL) at Strong Buy with Decreased Target to $20 on, Apr 1st, 2024

by: WOPRAI

Brandon King Maintained (CFR) at Hold with Increased Target to $121 on, Apr 1st, 2024

by: WOPRAI

Paul Newsome Maintained (UFCS) at Sell and Held Target at $21 on, Apr 1st, 2024

by: WOPRAI

Ed Arce Reiterated (UNCY) at Strong Buy and Held Target at $4.5 on, Apr 1st, 2024

by: WOPRAI

Brandon King Maintained (WTFC) at Strong Buy with Increased Target to $117 on, Apr 1st, 2024

by: WOPRAI

Joon Lee Reiterated (WVE) at Strong Buy and Held Target at $17 on, Apr 1st, 2024

by: WOPRAI

Josh Siegler Reiterated (WULF) at Buy and Held Target at $4 on, Apr 1st, 2024

by: WOPRAI

Michael Shlisky Upgraded (XOS) to Strong Buy and Held Target at $17 on, Apr 1st, 2024

by: WOPRAI

Jason Gabelman Maintained (XOM) at Strong Buy with Increased Target to $120 on, Apr 1st, 2024

by: WOPRAI

Michael Kupinski Maintained (TSQ) at Buy with Increased Target to $21 on, Apr 1st, 2024

by: WOPRAI

Andrew Uerkwitz Initiated (TTWO) at Strong Buy and Held Target at $195 on, Apr 1st, 2024

by: WOPRAI

Drew Crum Maintained (TTWO) at Strong Buy and Held Target at $175 on, Apr 1st, 2024

by: WOPRAI

Matt Olney Reiterated (VBTX) at Hold and Held Target at $24 on, Apr 1st, 2024

by: WOPRAI

Paul Newsome Maintained (UVE) at Buy and Held Target at $25 on, Apr 1st, 2024

by: WOPRAI

Scott Buck Maintained (USIO) at Strong Buy with Increased Target to $4 on, Apr 1st, 2024

by: WOPRAI

Li Watsek Reiterated (VINC) at Buy on, Apr 1st, 2024

by: WOPRAI

Alex Henderson Reiterated (VIAV) at Hold on, Apr 1st, 2024

by: WOPRAI

Ruben Roy Maintained (VIAV) at Strong Buy and Held Target at $13 on, Apr 1st, 2024

by: WOPRAI

Robert Burns Maintained (aplm) at Strong Buy with Decreased Target to $5 on, Apr 1st, 2024

by: WOPRAI

Michael King Maintained (aplm) at Strong Buy with Decreased Target to $6.5 on, Apr 1st, 2024

by: WOPRAI

Francois Brisebois Reiterated (ACHV) at Buy and Held Target at $18 on, Apr 1st, 2024

by: WOPRAI

Brandon King Maintained (ABCB) at Strong Buy with Decreased Target to $54 on, Apr 1st, 2024

by: WOPRAI

Ananda Baruah Maintained (AAPL) at Hold with Decreased Target to $170 on, Apr 1st, 2024

by: WOPRAI

Ken Gawrelski Maintained (ABNB) at Sell with Increased Target to $127 on, Apr 1st, 2024

by: WOPRAI

Derek Archila Maintained (ANNX) at Buy and Held Target at $12 on, Apr 1st, 2024

by: WOPRAI

Swayampakula Ramakanth Maintained (AFMD) at Strong Buy with Increased Target to $10 on, Apr 1st, 2024

by: WOPRAI

Bradley Canino Maintained (AFMD) at Hold with Increased Target to $5 on, Apr 1st, 2024

by: WOPRAI

Li Watsek Reiterated (AFMD) at Buy on, Apr 1st, 2024

by: WOPRAI

Yanan Zhu Maintained (AFMD) at Buy with Decreased Target to $25 on, Apr 1st, 2024

by: WOPRAI

Paul Newsome Maintained (AFG) at Hold and Held Target at $129 on, Apr 1st, 2024

by: WOPRAI

Matthew Hedberg Reiterated (ADSK) at Buy and Held Target at $320 on, Apr 1st, 2024

by: WOPRAI

Colin Langan Maintained (ADNT) at Buy with Decreased Target to $38 on, Apr 1st, 2024

by: WOPRAI

Etzer Darout Reiterated (ACRV) at Buy and Held Target at $18 on, Apr 1st, 2024

by: WOPRAI

Silvan Tuerkcan Reiterated (ACRV) at Buy and Held Target at $14 on, Apr 1st, 2024

by: WOPRAI

Vincent Colicchio Maintained (BBSI) at Buy and Held Target at $35 on, Apr 1st, 2024

by: WOPRAI

Brandon King Maintained (BANC) at Hold and Held Target at $16 on, Apr 1st, 2024

by: WOPRAI

Rob Wertheimer Downgraded (BA) to Hold on, Apr 1st, 2024

by: WOPRAI

Pablo Monsivais Maintained (AZUL) at Hold with Decreased Target to $12 on, Apr 1st, 2024

by: WOPRAI

Patrick Trucchio Maintained (ALT) at Strong Buy with Decreased Target to $12 on, Apr 1st, 2024

by: WOPRAI

Paul Newsome Maintained (ALL) at Buy with Increased Target to $188 on, Apr 1st, 2024

by: WOPRAI

George Staphos Downgraded (AMBP) to Sell and Decreased Target to $3.5 on, Apr 1st, 2024

Louise Chen Reiterated (zvra) at Buy on, Apr 1st, 2024

Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Apr 1st, 2024.

Louise has made no other calls on ZVRA in the last 4 months.



There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Louise

  • Tim Lugo of "William Blair" Initiated at Buy on, Tuesday, March 12th, 2024
  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Tuesday, March 5th, 2024

Like: 👍